On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair and CEO Dave Ricks. They ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...

The agency said that between its spinoff from Eli Lilly in 2019 and early 2020, Elanco used discounts and rebates to entice ...

The authority notes that six such products are currently being sold through websites, social media, and other informal ...

TRex Bio, a California biotechnology company that’s partnered with Eli Lilly and Johnson & Johnson ... are some of the most widely used and lucrative pharmaceutical products. But that hasn’t stopped ...

The stock of Eli Lilly and Company LLY has declined 10.6% in a month ... It is difficult to predict the demand/inventory ...

Eli Lilly and Company (NYSE ... The company is one of the two global leaders in diabetes with blockbuster products in Trulicity and recently launched Mounjaro (tirzepatide) to serve this large ...

Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week.

Following the drug's approval, a spokesperson for the Medicines and Healthcare products Regulatory Agency (MHRA ... severe ...

Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a ...